Works by Mugyenyi, Peter N.


Results: 9
    1
    2
    3
    4
    5
    6
    7
    8

    Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min

    Published in:
    PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225199
    By:
    • Ross, Lisa L.;
    • Walker, A. Sarah;
    • Lou, Yu;
    • Tenorio, Allan R.;
    • Gibb, Diana M.;
    • Double, Julia;
    • Gilks, Charles;
    • McCoig, Cynthia C.;
    • Munderi, Paula;
    • Musoro, Godfrey;
    • Kityo, Cissy M.;
    • Grosskurth, Heiner;
    • Hakim, James;
    • Mugyenyi, Peter N.;
    • Cutrell, Amy;
    • Perger, Teodora;
    • Shaefer, Mark S.
    Publication type:
    Article
    9